Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Quad
QUAD
$525M
| $36.5K | ﹤0.01% |
4,335
-5,647
| -57% | -$42.5K |
|
4352
Amplify Energy
AMPY
$205M
| $36.5K | ﹤0.01% |
9,164
-81,076
| -90% | -$416K |
|
|
WBTN
4353
WEBTOON Entertainment Inc
WBTN
$1.39B
| $36.4K | ﹤0.01% |
3,189
-12,863
| -80% | -$152K |
|
|
SPRB
4354
Spruce Biosciences
SPRB
$170M
| $36.4K | ﹤0.01% |
+674
| New | +$37.7K |
|
4355
Oramed Pharmaceuticals
ORMP
$207M
| $36.3K | ﹤0.01% |
7,537
-12,429
| -62% | -$49.5K |
|
4356
Standard BioTools
LAB
$272M
| $36.1K | ﹤0.01% |
43,919
-2,574,050
| -98% | -$2.43M |
|
4357
Espey Mfg & Electronics Corp
ESP
$189M
| $36.1K | ﹤0.01% |
536
-116
| -18% | -$7.35K |
|
|
SI
4358
Shoulder Innovations Inc
SI
$416M
| $35.9K | ﹤0.01% |
1,770
-415
| -19% | -$6.37K |
|
|
RNA
4359
Atrium Therapeutics
RNA
$194M
| $35.8K | ﹤0.01% |
2,699
+604
| +29% | +$7.89K |
|
4360
Distribution Solutions Group
DSGR
$1.61B
| $35.1K | ﹤0.01% |
1,282
-617
| -32% | -$16.9K |
|
4361
Cognyte Software
CGNT
$608M
| $34.9K | ﹤0.01% |
3,979
-1,857
| -32% | -$17.6K |
|
|
ANGX
4362
Angel Studios
ANGX
$908M
| $34.9K | ﹤0.01% |
9,507
+4,197
| +79% | +$11.9K |
|
|
SVCO
4363
Silvaco Group
SVCO
$229M
| $34.9K | ﹤0.01% |
2,528
-3,293
| -57% | -$34.2K |
|
|
AISP
4364
Airship AI Holdings
AISP
$71.6M
| $34.8K | ﹤0.01% |
14,565
-1,845
| -11% | -$4.71K |
|
4365
RGC Resources
RGCO
$225M
| $34.8K | ﹤0.01% |
1,455
-586
| -29% | -$13.5K |
|
4366
Alpha Teknova
TKNO
$369M
| $34.7K | ﹤0.01% |
6,117
-325
| -5% | -$1.29K |
|
4367
Blue Ridge Bankshares
BRBS
$359M
| $34.7K | ﹤0.01% |
9,822
-6,189
| -39% | -$21.5K |
|
4368
AMES National
ATLO
$286M
| $34.6K | ﹤0.01% |
1,167
-383
| -25% | -$11.1K |
|
|
CNTN
4369
Canton Strategic Holdings
CNTN
$178M
| $34.5K | ﹤0.01% |
+12,241
| New | +$38.7K |
|
4370
iShares MSCI EAFE Value ETF
EFV
$32B
| $34.1K | ﹤0.01% |
445
-445
| -50% | -$34.5K |
|
|
ACH
4371
Accendra Health
ACH
$84.6M
| $34K | ﹤0.01% |
9,939
-5,339
| -35% | -$16.6K |
|
4372
TTEC Holdings
TTEC
$66.1M
| $34K | ﹤0.01% |
17,508
-1,797
| -9% | -$4.64K |
|
4373
Advantage Solutions
ADV
$396M
| $33.9K | ﹤0.01% |
784
-147
| -16% | -$5.2K |
|
|
BRCB
4374
Black Rock Coffee Bar Inc
BRCB
$212M
| $33.8K | ﹤0.01% |
4,076
+766
| +23% | +$7.63K |
|
4375
The ONE Group
STKS
$51.1M
| $33.7K | ﹤0.01% |
16,768
+112
| +0.7% | +$208 |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.